Cargando…
Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells
At present, chemotherapy is the most effective strategy for treating triple-negative breast cancer (TNBC), but its efficacy was limited by the development of chemo-resistance. The exact mechanism of chemoresistance still remains unclear. This study aims to examine whether 6-phosphogluconate dehydrog...
Autores principales: | Xu, Jiali, Ren, Guosheng, Cheng, Qiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416659/ https://www.ncbi.nlm.nih.gov/pubmed/37559469 http://dx.doi.org/10.1177/15330338231190737 |
Ejemplares similares
-
Autophagy and Glycometabolic Reprograming in the Malignant Progression of Lung Cancer: A Review
por: Li, Yuting, et al.
Publicado: (2023) -
Biological Role and Mechanism of Lipid Metabolism Reprogramming
Related Gene ECHS1 in Cancer
por: Hu, Teng, et al.
Publicado: (2022) -
Multi-omics Analysis of the Role of PHGDH in Colon
Cancer
por: Dai, Zhihui, et al.
Publicado: (2023) -
Folate Metabolism in Hepatocellular Carcinoma. What Do We Know So Far?
por: Quevedo-Ocampo, Jaqueline, et al.
Publicado: (2022) -
NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis
por: Sun, Linjuan, et al.
Publicado: (2023)